• Open Access

Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease

Authors

  • Amit Batla MD DM,

    1. Sobell Department of Motor Neuroscience and Movement, Disorders UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author
  • Maria Stamelou MD, PhD,

    1. Sobell Department of Motor Neuroscience and Movement, Disorders UCL Institute of Neurology, London, United Kingdom
    Search for more papers by this author
  • Niccolo Mencacci MD,

    1. UCL Institute of Neurology, Department of Molecular, Neuroscience London, United Kingdom
    2. IRCCS Istituto Auxologico Italiano, Universita' di Milano, Department of Neurology and Laboratory of Neuroscience, Milan, Italy
    Search for more papers by this author
  • Anthony H. Schapira DSc, MD, FRCP, FMedSci,

    1. Department of Clinical Neurosciences, UCL Institute of Neurology London, United Kingdom
    Search for more papers by this author
  • Kailash P. Bhatia MD, FRCP

    Corresponding author
    1. Sobell Department of Motor Neuroscience and Movement, Disorders UCL Institute of Neurology, London, United Kingdom
    • Correspondence to: Prof. Kailash P. Bhatia, MD Sobell Department of Motor Neuroscience and Movement Disorders UCL Institute of Neurology, London, United Kingdom; k.bhatia@ion.ucl.ac.uk

    Search for more papers by this author

  • Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://olabout.wiley.com/WileyCDA/Section/id-817008.html

  • Relevant conflicts of interest/financial disclosures: Nothing to report.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary